LDL-P
LDL particle number — counts the actual number of LDL particles, regardless of the cholesterol they carry.
Optimal Range
< 1000 nmol/L (optimal) · < 1300 nmol/L (normal)
Risk-Stratified Targets
| Population / Context | Target |
|---|---|
| Optimal | < 1000 nmol/L |
| Near optimal | 1000–1299 nmol/L |
| Borderline high | 1300–1599 nmol/L |
| High | ≥ 1600 nmol/L |
Why It Matters
Two people with the same LDL-C can have vastly different particle counts. Higher particle numbers mean more chances for arterial wall penetration, making LDL-P a better risk discriminator than LDL-C alone.
Understanding LDL-P
LDL particle number (LDL-P) measures the actual count of LDL particles circulating in your blood, typically using nuclear magnetic resonance (NMR) spectroscopy. While LDL-C tells you how much cholesterol is being carried, LDL-P tells you how many 'vehicles' are carrying it — and it is the number of vehicles, not the cargo, that determines how many can penetrate your arterial walls.
This distinction is clinically meaningful in a significant subset of patients. When metabolic syndrome, insulin resistance, or type 2 diabetes are present, the liver tends to produce more small, dense LDL particles. Each particle carries less cholesterol, so LDL-C may appear normal or only mildly elevated — while the actual particle count (LDL-P) is significantly high. This is one of the most common patterns of LDL-C/LDL-P discordance and explains why many heart attacks occur in people with 'normal' cholesterol.
LDL-P and ApoB provide largely redundant information since each LDL particle carries exactly one ApoB molecule. In clinical practice, ApoB is more widely available and less expensive to measure. However, NMR-based LDL-P testing also provides particle size distribution, which can offer additional insights into metabolic health.
Key Research
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study
Cromwell WC et al. · J Clin Lipidol (2007)
Key finding: LDL-P was a stronger predictor of cardiovascular events than LDL-C, particularly when the two measures were discordant.